Capricor Therapeutics | CAPR - Ebitda


Capricor Therapeutics reported $-27.23M in EBITDA for its fiscal quarter ending in June of 2025.





Ebitda Change Date
Alterity Therapeutics Limited AUD -7.72M 2.99M Jun/2023
Bioline Rx USD -2.25M 1.7M Mar/2026
Capricor Therapeutics USD -27.23M 2.66M Jun/2025
Cipla INR 14.03B 4.48B Jun/2026
Cytokinetics USD -169.32M 19.48M Mar/2026
Geron USD 3.83M 25.12M Mar/2026
Grifols EUR 482.04M 7.04M Sep/2025
Immunic USD -22.78M 753K Jun/2024
J&J USD 8.27B 1.08B Mar/2026
Plus Therapeutics USD -4.4M 2.94M Sep/2025
Prothena USD 25.98M 65.51M Mar/2026
PTC Therapeutics USD 61.98M 132.97M Mar/2026
Sarepta Therapeutics USD 375.48M 627.68M Mar/2026